Home » Topics » BioWorld Science

BioWorld Science
RSS

Juva adds second novel noncannabinoid compound to pipeline

Nov. 15, 2021

Systems biology approaches unveil in vivo commensal control of Clostridioides difficile virulence

Nov. 15, 2021

Targeting pathogenic activation of autophagy in a new LGMDD2 fly model rescues muscle phenotypes

Nov. 15, 2021

EIF4 inhibitor pateamine A improves immunological and neurological functioning in murine lupus model

Nov. 15, 2021

ADAR1 Z alpha-domain-mutated mice display Aicardi-Goutieres syndrome defects

Nov. 15, 2021

Seno-7284 shows efficacy in preclinical models of age-related cardiometabolic disease

Nov. 15, 2021

UCARTMESO, MSLN-targeting allogeneic CAR T cells with preclinical efficacy against solid tumors

Nov. 15, 2021

PA-001 for COVID-19 completes preclinical testing

Nov. 15, 2021

BACE1 inhibition may find new target in glioblastoma

Nov. 15, 2021

First preclinical results of AB-201, a novel allogeneic anti-HER2 CAR NK-cell therapy

Nov. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...